VenoStent is a venture backed, clinical stage medical device and tissue engineering company developing bioabsorbable wraps to transform outcomes in vascular surgery

U.S. Department of Health & Human Services

Y Combinator

Olima Ventures

IAG Capital Partners

Kube VC

C3 Ventures

Cowtown Angels

SP Investment Fund

Texas HALO Fund

Creative Ventures

Adam Morley

VenoStent, Inc.

Invizius is a competitor of VenoStent in the medical device industry, focusing on innovative solutions for venous insufficiency and related conditions.

Invizius

Renal Solutions competes with VenoStent in the medical device sector, particularly in the area of minimally invasive devices for venous function restoration and symptom reduction related to chronic venous insufficiency.

Renal Solutions

Laminate Medical Technologies is a competitor of VenoStent, specializing in medical devices for venous function restoration and addressing chronic venous insufficiency.

Laminate Medical Technologies

Vascular Therapies competes with VenoStent in the medical device industry, particularly in the development of minimally invasive devices for venous function restoration and symptom reduction related to chronic venous insufficiency.

Vascular Therapies

Redsense Medical is a competitor of VenoStent in the medical device industry, particularly in the area of minimally invasive devices for venous function restoration and symptom reduction related to chronic venous insufficiency.

Redsense Medical

Eikon Therapeutics competes with VenoStent in the medical device sector, focusing on innovative solutions for venous insufficiency and related conditions.

Eikon Therapeutics

nference is a competitor of VenoStent in the medical device industry, particularly in the area of minimally invasive devices for venous function restoration and symptom reduction related to chronic venous insufficiency.

nference

Carisma Therapeutics competes with VenoStent in the medical device industry, particularly in the development of minimally invasive devices for venous function restoration and symptom reduction related to chronic venous insufficiency.

Carisma Therapeutics

Venostent is a medical device company focused on improving the standard of care for patients with chronic venous insufficiency (CVI). The company has developed a minimally invasive device designed to restore venous function and reduce the symptoms associated with CVI.

Venostent

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	May 15, 2024 12:21 PM	48607ef3
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general
crunchbase trigger	general
crunchbase profile	general
li profile	general	May 15, 2024 12:21 PM	ad60c103
translate crunchbase fundingrounds	general
peers	general
news basic	general
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

COM:VENOSTENT

Venostent